You are here

BEXION PHARMACEUTICALS, INC.

Company Information
Address
632 Russell St
Covington, KY 41011-
United States



Information

UEI: HJPDQTK95NS8

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme

    Amount: $2,857,272.00

    DESCRIPTION (provided by applicant): Our goal is to develop a new molecular entity with a novel mechanism of action for targeting and eliminating glioblastoma multiforme (GBM, high grade glioma), a de ...

    SBIRPhase II2013Department of Health and Human Services National Institutes of Health
  2. SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme

    Amount: $2,857,272.00

    DESCRIPTION provided by applicant Our goal is to develop a new molecular entity with a novel mechanism of action for targeting and eliminating glioblastoma multiforme GBM high grade glioma a de ...

    SBIRPhase II2013Department of Health and Human Services National Institutes of Health
  3. SapC-DOPS nanovesicles for Treating Glioblastoma Multiforme

    Amount: $1,511,320.00

    DESCRIPTION (provided by applicant): Our goal is to develop a new molecular entity with a novel mechanism of action for targeting and eliminating glioblastoma multiforme (GBM, high grade glioma), ...

    SBIRPhase II2010Department of Health and Human Services National Institutes of Health
  4. SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme

    Amount: $273,138.00

    DESCRIPTION (provided by applicant): We are proposing to develop a new treatment for targeting and eliminating glioblastoma multiforme (GBM, high grade glioma), a deadly and invasive brain tumor with ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
  5. A Novel Biotherapeutic Treatment for Pancreatic Cancer

    Amount: $99,965.00

    DESCRIPTION (provided by applicant): Carcinoma of the pancreas is the 4th leading cause of cancer deaths. The American Cancer Society has estimated 37,170 new cases and 33,370 deaths in 2007. The canc ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
  6. A novel biotherapeutic treatment for prostate cancer

    Amount: $145,306.00

    DESCRIPTION (provided by applicant): The American Cancer Society estimated a total of 1,372,910 new cancer cases and 570,280 cancer deaths in the U. S. in 2005. The National Cancer Institute solicits ...

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government